Pharmanutra Statements
PH
Data from Pharmanutra`s earning releases including common size income statement and balance sheet.
Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.
Key Information:
Report currency:
EUR - Euro
Last reporting period:
30 Sep, 2023
Next reporting period:
29 Dec, 2023
Report frequency:
Quarterly
Earnings release date:
—
Expected release date:
—
Pharmanutra Income Statement
B
M
EUR (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
21.802
-56.1 %
100
0.332
1.5
21.47
-55.6 %
98.5
0.271
1.2
16.286
74.7
16.905
-51.9 %
77.5
4.565
-65.5 %
20.9
-0.165
-0.8
0.089
0.4
4.489
-66 %
20.6
1.99
9.1
2.499
-65.4 %
11.5
0.26
9.616
49.632
15.4 %
100
1.288
2.6
48.344
15.8 %
97.4
0.456
0.9
34.059
68.6
35.127
15.1 %
70.8
13.217
17.8 %
26.6
-0.118
-0.2
0.125
0.3
13.207
13.9 %
26.6
5.975
12
7.232
6.1 %
14.6
0.752
9.616
43.013
109.2 %
100
1.28
3
41.733
108.4 %
97
0.308
0.7
29.564
68.7
30.514
122.4 %
70.9
11.219
78.1 %
26.1
0.026
0.06
0.352
0.8
11.597
74.7 %
27
4.781
11.1
6.816
47.9 %
15.8
0.705
9.671
20.559
-48.2 %
100
0.535
2.6
20.024
-47.5 %
97.4
0.165
0.8
13.073
63.6
13.723
-47.8 %
66.7
6.301
-46.8 %
30.6
0.006
0.03
0.332
1.6
6.639
-43.8 %
32.3
2.005
9.8
4.607
-44 %
22.4
0.48
9.592
39.711
110.8 %
100
1.545
3.9
38.166
109.2 %
96.1
0.197
0.5
25.545
64.3
26.311
98.4 %
66.3
11.855
138.1 %
29.9
0.01
0.03
-0.01
-0.03
11.821
137.4 %
29.8
3.589
9
8.232
136.1 %
20.7
0.851
9.674
18.84
-47.4 %
100
0.598
3.2
18.242
-47.8 %
96.8
0.08
0.4
12.919
68.6
13.264
-49 %
70.4
4.978
-44.5 %
26.4
0.009
0.05
-0.002
-0.01
4.98
-44.8 %
26.4
1.494
7.9
3.486
-48.2 %
18.5
0.36
9.683
35.841
110.4 %
100
0.883
2.5
34.958
110.1 %
97.5
—
0
25.411
70.9
25.986
127.6 %
72.5
8.972
71.8 %
25
0.061
0.2
-0.01
-0.03
9.023
72.4 %
25.2
2.292
6.4
6.731
75 %
18.8
0.693
9.718
17.033
-47.2 %
100
0.395
2.3
16.638
-46.1 %
97.7
—
0
11.165
65.5
11.416
-46 %
67
5.222
-46.3 %
30.7
0.019
0.1
0.003
0.02
5.234
-46.5 %
30.7
1.388
8.1
3.846
-45.4 %
22.6
0.39
9.871
32.273
126.7 %
100
1.41
4.4
30.863
128.6 %
95.6
—
0
20.411
63.2
21.135
112.8 %
65.5
9.728
172.6 %
30.1
0.067
0.2
—
0
9.786
172.4 %
30.3
2.746
8.5
7.04
180.6 %
21.8
0.73
9.644
14.238
-47.9 %
100
0.736
5.2
13.502
-47.7 %
94.8
—
0
9.655
67.8
9.934
-52.5 %
69.8
3.568
-27 %
25.1
0.025
0.2
—
0
3.593
-27 %
25.2
1.084
7.6
2.509
-42.9 %
17.6
0.26
9.65
27.337
-6.1 %
100
1.536
5.6
25.801
-7.6 %
94.4
—
0
19.924
72.9
20.914
6.7 %
76.5
4.887
-41.4 %
17.9
0.032
0.1
0.005
0.02
4.924
-41.2 %
18
0.531
1.9
4.393
-54.6 %
16.1
0.454
9.681
29.112
1.7 %
100
1.181
4.1
27.931
3.2 %
95.9
—
0
19.073
65.5
19.597
-5.4 %
67.3
8.334
31.1 %
28.6
0.061
0.2
-0.012
-0.04
8.378
31.8 %
28.8
-1.301
-4.5
9.679
116.3 %
33.2
1
9.681
28.626
14.6 %
100
1.56
5.5
27.066
14.3 %
94.5
—
0
20.411
71.3
20.707
16.2 %
72.3
6.359
8.3 %
22.2
-0.001
-0.003
-0.001
-0.003
6.357
8.9 %
22.2
1.883
6.6
4.474
12.4 %
15.6
0.462
9.681
24.981
1.3 %
100
1.295
5.2
23.686
0.7 %
94.8
—
0
17.116
68.5
17.814
6.4 %
71.3
5.872
-13.2 %
23.5
0.007
0.03
-0.012
-0.05
5.84
-13.1 %
23.4
1.86
7.4
3.98
-20.3 %
15.9
0.411
9.681
24.664
12.1 %
100
1.154
4.7
23.51
13.6 %
95.3
—
0
17.571
71.2
16.743
7.8 %
67.9
6.767
31.1 %
27.4
0.004
0.02
-0.038
-0.2
6.719
30.9 %
27.2
1.726
7
4.993
40.1 %
20.2
0.516
9.681
22.008
13.2 %
100
1.318
6
20.691
10.6 %
94
—
0
15.03
68.3
15.527
9.9 %
70.6
5.163
12.8 %
23.5
-0.025
-0.1
-0.003
-0.01
5.135
13.7 %
23.3
1.57
7.1
3.565
14.5 %
16.2
0.368
9.681
19.435
5.9 %
100
0.722
3.7
18.713
8 %
96.3
—
0
13.731
70.7
14.135
8.5 %
72.7
4.578
6.6 %
23.6
0.005
0.03
-0.055
-0.3
4.516
6.2 %
23.2
1.402
7.2
3.114
6.8 %
16
0.251
12.412
18.359
—
100
1.039
5.7
17.32
—
94.3
—
0
12.632
68.8
13.027
—
71
4.293
—
23.4
-0.039
-0.2
0
-0.002
4.254
—
23.2
1.337
7.3
2.917
—
15.9
0.42
6.95